OMEROS CORP (OMER) Fundamental Analysis & Valuation

NASDAQ:OMER • US6821431029

11.54 USD
+0.05 (+0.44%)
At close: Mar 6, 2026
11.42 USD
-0.12 (-1.04%)
After Hours: 3/6/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This OMER fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

0

Overall OMER gets a fundamental rating of 0 out of 10. We evaluated OMER against 193 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of OMER have multiple concerns. OMER is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. OMER Profitability Analysis

1.1 Basic Checks

  • OMER had negative earnings in the past year.
  • In the past year OMER has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: OMER reported negative net income in multiple years.
  • In the past 5 years OMER reported 4 times negative operating cash flow.
OMER Yearly Net Income VS EBIT VS OCF VS FCFOMER Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • OMER's Return On Assets of -65.24% is on the low side compared to the rest of the industry. OMER is outperformed by 68.91% of its industry peers.
Industry RankSector Rank
ROA -65.24%
ROE N/A
ROIC N/A
ROA(3y)-26.61%
ROA(5y)-21.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OMER Yearly ROA, ROE, ROICOMER Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for OMER so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OMER Yearly Profit, Operating, Gross MarginsOMER Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. OMER Health Analysis

2.1 Basic Checks

  • OMER has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, OMER has more shares outstanding
  • The debt/assets ratio for OMER is higher compared to a year ago.
OMER Yearly Shares OutstandingOMER Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OMER Yearly Total Debt VS Total AssetsOMER Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • OMER has an Altman-Z score of -8.69. This is a bad value and indicates that OMER is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of OMER (-8.69) is worse than 66.32% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.69
ROIC/WACCN/A
WACCN/A
OMER Yearly LT Debt VS Equity VS FCFOMER Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.89 indicates that OMER may have some problems paying its short term obligations.
  • OMER has a Current ratio of 0.89. This is amonst the worse of the industry: OMER underperforms 86.01% of its industry peers.
  • OMER has a Quick Ratio of 0.89. This is a bad value and indicates that OMER is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.89, OMER is not doing good in the industry: 78.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.89
OMER Yearly Current Assets VS Current LiabilitesOMER Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. OMER Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.55% over the past year.
EPS 1Y (TTM)12.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 32.07% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y23.22%
EPS Next 2Y17.61%
EPS Next 3Y18.13%
EPS Next 5Y32.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OMER Yearly Revenue VS EstimatesOMER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
OMER Yearly EPS VS EstimatesOMER Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

0

4. OMER Valuation Analysis

4.1 Price/Earnings Ratio

  • OMER reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year OMER is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OMER Price Earnings VS Forward Price EarningsOMER Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OMER Per share dataOMER EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -1 -2 -3

4.3 Compensation for Growth

  • OMER's earnings are expected to grow with 18.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.61%
EPS Next 3Y18.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OMER Dividend Analysis

5.1 Amount

  • No dividends for OMER!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OMER Fundamentals: All Metrics, Ratios and Statistics

OMEROS CORP

NASDAQ:OMER (3/6/2026, 8:00:02 PM)

After market: 11.42 -0.12 (-1.04%)

11.54

+0.05 (+0.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-13
Earnings (Next)03-30
Inst Owners46.66%
Inst Owner Change1.01%
Ins Owners2.77%
Ins Owner Change-29.19%
Market Cap818.19M
Revenue(TTM)N/A
Net Income(TTM)-121.16M
Analysts80
Price Target44.54 (285.96%)
Short Float %26.05%
Short Ratio7.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.4%
Min EPS beat(2)-3.55%
Max EPS beat(2)12.36%
EPS beat(4)2
Avg EPS beat(4)10.09%
Min EPS beat(4)-3.55%
Max EPS beat(4)31.91%
EPS beat(8)5
Avg EPS beat(8)18.23%
EPS beat(12)8
Avg EPS beat(12)50.79%
EPS beat(16)11
Avg EPS beat(16)44.44%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)29.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.76%
EPS NY rev (1m)0.12%
EPS NY rev (3m)-7.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.02
EYN/A
EPS(NY)-1.67
Fwd EYN/A
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-1.48
OCFYN/A
SpS0
BVpS-3.11
TBVpS-3.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -65.24%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-26.61%
ROA(5y)-21.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.83%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.89
Altman-Z -8.69
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)25.18%
Cap/Depr(5y)22.56%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.07%
EPS Next Y23.22%
EPS Next 2Y17.61%
EPS Next 3Y18.13%
EPS Next 5Y32.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-225.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-225.02%
OCF growth 3YN/A
OCF growth 5YN/A

OMEROS CORP / OMER FAQ

What is the ChartMill fundamental rating of OMEROS CORP (OMER) stock?

ChartMill assigns a fundamental rating of 0 / 10 to OMER.


What is the valuation status of OMEROS CORP (OMER) stock?

ChartMill assigns a valuation rating of 0 / 10 to OMEROS CORP (OMER). This can be considered as Overvalued.


Can you provide the profitability details for OMEROS CORP?

OMEROS CORP (OMER) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for OMER stock?

The Earnings per Share (EPS) of OMEROS CORP (OMER) is expected to grow by 23.22% in the next year.